Maini, R., St Clair, E., Breedveld, F., Furst, D., Kalden, J., Weisman, M., . . . Lipsky, P. (1999). Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial. ATTRACT Study Group.
Citace podle Chicago (17th ed.)Maini, R., et al. Infliximab (chimeric Anti-tumour Necrosis Factor Alpha Monoclonal Antibody) Versus Placebo in Rheumatoid Arthritis Patients Receiving Concomitant Methotrexate: A Randomised Phase III Trial. ATTRACT Study Group. 1999.
Citace podle MLA (9th ed.)Maini, R., et al. Infliximab (chimeric Anti-tumour Necrosis Factor Alpha Monoclonal Antibody) Versus Placebo in Rheumatoid Arthritis Patients Receiving Concomitant Methotrexate: A Randomised Phase III Trial. ATTRACT Study Group. 1999.